TF and neoplasm: These TFs included tumor-promoting ZKSCAN1 from the open chromatin regions of metastatic patients and tumor suppressor HNF1B from the open chromatin regions of non-metastases patients; and this can remodel chromatin landscape and accessibility to recruit or prevent TF binding as a mechanism to initiate tumor metastasis (93).